Literature DB >> 17727268

Design of new plasmepsin inhibitors: a virtual high throughput screening approach on the EGEE grid.

Vinod Kasam1, Marc Zimmermann, Astrid Maass, Horst Schwichtenberg, Antje Wolf, Nicolas Jacq, Vincent Breton, Martin Hofmann-Apitius.   

Abstract

Though different species of the genus Plasmodium may be responsible for malaria, the variant caused by P. falciparum is often very dangerous and even fatal if untreated. Hemoglobin degradation is one of the key metabolic processes for the survival of the Plasmodium parasite in its host. Plasmepsins, a family of aspartic proteases encoded by the Plasmodium genome, play a prominent role in host hemoglobin cleavage. In this paper we demonstrate the use of virtual screening, in particular molecular docking, employed at a very large scale to identify novel inhibitors for plasmepsins II and IV. A large grid infrastructure, the EGEE grid, was used to address the problem of large computation resources required for docking hundreds of thousands of chemical compounds on different plasmepsin targets of P. falciparum. A large compound library of about 1 million chemical compounds was docked on 5 different targets of plasmepsins using two different docking software, namely FlexX and AutoDock. Several strategies were employed to analyze the results of this virtual screening approach including docking scores, ideal binding modes, and interactions to key residues of the protein. Three different classes of structures with thiourea, diphenylurea, and guanidino scaffolds were identified to be promising hits. While the identification of diphenylurea compounds is in accordance with the literature and thus provides a sort of "positive control", the identification of novel compounds with a guanidino scaffold proves that high throughput docking can be effectively used to identify novel potential inhibitors of P. falciparum plasmepsins. Thus, with the work presented here, we do not only demonstrate the relevance of computational grids in drug discovery but also identify several promising small molecules which have the potential to serve as candidate inhibitors for P. falciparum plasmepsins. With the use of the EGEE grid infrastructure for the virtual screening campaign against the malaria causing parasite P. falciparum we have demonstrated that resource sharing on an eScience infrastructure such as EGEE provides a new model for doing collaborative research to fight diseases of the poor.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17727268     DOI: 10.1021/ci600451t

Source DB:  PubMed          Journal:  J Chem Inf Model        ISSN: 1549-9596            Impact factor:   4.956


  13 in total

1.  Improved prediction of malaria degradomes by supervised learning with SVM and profile kernel.

Authors:  Rui Kuang; Jianying Gu; Hong Cai; Yufeng Wang
Journal:  Genetica       Date:  2008-12-06       Impact factor: 1.082

2.  Comparative Genomics and Systems Biology of Malaria Parasites Plasmodium.

Authors:  Hong Cai; Zhan Zhou; Jianying Gu; Yufeng Wang
Journal:  Curr Bioinform       Date:  2012-12-01       Impact factor: 3.543

3.  Computational perspectives into plasmepsins structure-function relationship: implications to inhibitors design.

Authors:  Alejandro Gil L; Pedro A Valiente; Pedro G Pascutti; Tirso Pons
Journal:  J Trop Med       Date:  2011-07-03

4.  Expanding the Antimalarial Drug Arsenal-Now, But How?

Authors:  Brian T Grimberg; Rajeev K Mehlotra
Journal:  Pharmaceuticals (Basel)       Date:  2011-05-01

5.  Proteases in malaria parasites - a phylogenomic perspective.

Authors:  Hong Cai; Rui Kuang; Jianying Gu; Yufeng Wang
Journal:  Curr Genomics       Date:  2011-09       Impact factor: 2.236

6.  Current developments in the therapy of protozoan infections.

Authors:  Mario Zucca; Dianella Savoia
Journal:  Open Med Chem J       Date:  2011-03-09

7.  Structure-based and ligand-based virtual screening of novel methyltransferase inhibitors of the dengue virus.

Authors:  See Ven Lim; Mohd Basyaruddin A Rahman; Bimo A Tejo
Journal:  BMC Bioinformatics       Date:  2011-11-30       Impact factor: 3.169

8.  Trafficked Proteins-Druggable in Plasmodium falciparum?

Authors:  Jasmin Lindner; Kamila Anna Meissner; Isolmar Schettert; Carsten Wrenger
Journal:  Int J Cell Biol       Date:  2013-04-28

9.  WISDOM-II: screening against multiple targets implicated in malaria using computational grid infrastructures.

Authors:  Vinod Kasam; Jean Salzemann; Marli Botha; Ana Dacosta; Gianluca Degliesposti; Raul Isea; Doman Kim; Astrid Maass; Colin Kenyon; Giulio Rastelli; Martin Hofmann-Apitius; Vincent Breton
Journal:  Malar J       Date:  2009-05-01       Impact factor: 2.979

10.  Theoretical and experimental studies of new modified isoflavonoids as potential inhibitors of topoisomerase I from Plasmodium falciparum.

Authors:  Wilian A Cortopassi; Julia Penna-Coutinho; Anna C C Aguiar; André S Pimentel; Camilla D Buarque; Paulo R R Costa; Bruna R M Alves; Tanos C C França; Antoniana U Krettli
Journal:  PLoS One       Date:  2014-03-20       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.